UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai
|
2020-08-24 18:01
라인
GC Pharma collects more plasma to speed up work on Covid-19 treatment
GC Pharma said it would collect more plasma from recovered Covid-19 patient...
by Kim Chan-hyuk
|
2020-08-24 17:15
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Despite fall in new virus cases, calls rise for tightest social distancing
New virus cases dropped below 300 on Monday, but epidemiological experts ca...
by Shim Hyun-tai
|
2020-08-24 15:42
라인
Korea’s healthcare exports expand 36% in July
The nation’s exports of healthcare products rose 36 percent in July from a ...
by Kwak Sung-sun
|
2020-08-24 14:54
라인
‘Daily confirmed cases could hit 2,800 in 2 weeks if left uncontrolled’
The health authorities must implement the toughest social distancing to con...
by Song Soo-youn
|
2020-08-24 11:39
라인
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
Korea’s new virus cases exceeded 300 for two consecutive days on Saturday, ...
by Shim Hyun-tai
|
2020-08-22 19:08
라인
Seoul using near 80% of Covid-19 sickbeds
Out of the 1,118 sickbeds for the Covid-19 patients in the Seoul metro regi...
by Shim Hyun-tai
|
2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments
As global competition heats up to secure the Covid-19 vaccines, the Korean ...
by Shim Hyun-tai
|
2020-08-21 16:06
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
An increasing number of pharmaceutical companies are holding the activities...
by Kim Yun-mi
|
2020-08-21 16:00
라인
Hanmi terminates global P2 trial for poziotinib
Hanmi Pharmaceutical has terminated its global phase 2 clinical trial for p...
by Lee Han-soo
|
2020-08-21 15:56
라인
‘Metastatic pancreatic cancer needs insurance benefit for Onyvide+5-FU/LV’
Patients with metastatic pancreatic cancer, notorious for high fatality, ne...
by Kim Yun-mi
|
2020-08-21 15:21
라인
New virus cases top 300; tighter restrictions eyed in greater Seoul
Korea's daily Covid-19 cases surpassed 300 as community outbreaks conti...
by Lee Han-soo
|
2020-08-21 14:29
라인
‘Almost all patients with aortic stenosis will get TAVI by 2025’
“In the PARTNER 3 clinical trial for low-risk patients, Transcatheter Aorti...
by Kim Chan-hyuk
|
2020-08-21 14:24
라인
Samsung Bioepis wins European nod for Avastin biosimilar
Samsung Bioepis said that it has obtained a sales approval for Aybintio, a ...
by Lee Han-soo
|
2020-08-21 11:32
라인
Daewoong to co-develop esophagitis drug for treating Covid-19
Daewoong Pharmaceutical signed an agreement with Institut Pasteur Korea (IP...
by Shim Hyun-tai
|
2020-08-20 18:41
라인
Korea speeds up developing coronavirus-related products
The government plans to accelerate the development of Covid-19 diagnostic k...
by Shim Hyun-tai
|
2020-08-20 17:58
라인
Bioneer to donate 10,000 Covid-19 test kits to Lebanon
Korean biotech company Bioneer said it would donate 10,000 Covid-19 diagnos...
by Kim Chan-hyuk
|
2020-08-20 17:01
라인
Yuhan licenses out gastrointestinal treatment to US partner
Yuhan Corp. said that it has licensed out YH12852, a gastrointestinal motil...
by Lee Han-soo
|
2020-08-20 16:58
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top